Jackson 10-Q Details Q3 EPS of $12.37 and a $4.7B AOCI Hit to Book Value
JXN sits 57% above its 52-week low of $89.67.
Summary
Jackson's Q3 10-Q confirms $847 million of net income to common ($12.37 diluted) and $517 million of adjusted operating earnings, while a $2.2 billion after-tax AOCI loss pulled shareholders' equity down to $8.5 billion.
Key Events · Earnings and Guidance · JXN
-
Q3 Net Income Jumps to $847M
Net income attributable to common shareholders was $847 million, or $12.37 per diluted share, versus $65 million ($0.92) a year earlier; adjusted operating earnings were $517 million ($7.55) versus $433 million ($6.16).
-
AOCI Loss Cuts Book Value
Accumulated other comprehensive loss widened to $4,664 million from $2,470 million at December 31, 2025, taking total shareholders' equity to $8,481 million from $9,953 million.
-
Tax Valuation Allowance Up $538M
The company added $538 million to its valuation allowance in the nine months ($431 million in Q3), bringing the total to $1,024 million on unrealized available-for-sale tax losses and charitable carryover.
-
Retail Annuity Sales Up 22%
Total sales were $7,282 million in Q3 versus $6,365 million, led by RILA sales of $2,967 million (from $2,066 million) and fixed index annuity sales of $627 million (from $73 million).
Analysis · JXN · Finance
The headline numbers were already out today, but the full 10-Q shows what sits underneath them. Q3 net income to common was $847 million ($12.37 diluted) against $65 million a year ago, and adjusted operating earnings rose to $517 million ($7.55) from $433 million. The catch is the balance sheet: accumulated other comprehensive income fell to a $4,664 million loss from $2,470 million at year-end, cutting total shareholders' equity to $8,481 million from $9,953 million, and the company added $538 million to its tax valuation allowance in the nine months. That gap between a strong GAAP quarter and a shrinking book value is the real story for anyone valuing JXN on book. Capital return remains the offset: $838 million returned in the first nine months, a $1 billion buyback increase, and free capital generation of $856 million with a 2026 target at or above $1.2 billion.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JXN was trading at $140.65 on NYSE in the Finance sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $89.67 to $143.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.